Quantitative determination of taurine and related biomarkers in urine by liquid chromatography-tandem mass spectrometry

Analytical and Bioanalytical Chemistry

Volumn 402, Issue 2, 2012, Pages 763-770

  Gamagedara, Sanjeewa ^a   Shi, Honglan ^a   Ma, Yinfa ^a  

^a MISSOURI UNIVERSITY OF SCIENCE AND TECHNOLOGY   (United States)

Author keywords

Biomarkers; Bladder cancer; LC MS MS; Taurine; Urine

Indexed keywords

ANALYTES; ANALYTICAL TECHNIQUES; BLADDER CANCERS; HIPPURIC ACID; INTERNAL STANDARDS; INVASIVE METHODS; IONIZATION MODES; ISOCRATIC CONDITIONS; L-GLUTAMINE; L-PHENYLALANINE; LC-MS/MS; LIMIT OF DETECTION; LIMIT OF QUANTITATIONS; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; LOW LEVEL; MULTIPLE REACTION MONITORING; NONINVASIVE METHODS; PHYSIOLOGICAL FLUIDS; QUANTITATIVE DETERMINATIONS; SIMPLE METHOD; SIMPLE MODIFICATIONS; TAURINE; URINARY BLADDER CANCER; URINE; URINE DILUTION;

AMINO ACIDS; BIOMARKERS; BODY FLUIDS; DIAGNOSIS; DISEASES; FORMIC ACID; LIQUIDS; MASS SPECTROMETRY; METHANOL; NONINVASIVE MEDICAL PROCEDURES; SEPARATION;

LIQUID CHROMATOGRAPHY;

BIOLOGICAL MARKER; TAURINE;

ARTICLE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; URINE;

BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; TAURINE;

EID: 84856216340     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-011-5491-4     Document Type: Article

References (27)

1. JA Sturman 1993 Taurine in development Physiol Rev 73 1 119 147 1:CAS:528:DyaK3sXhvVyhtrc%3D
2. K Fukuda Y Hirai H Yoshida T Nakajima T Usui 1982 Free amino acid content of lymphocytes and granulocytes compared Clin Chem 28 8 1758 1761 1:CAS:528:DyaL38Xlt1ensro%3D (Pubitemid 12039726)
3. DL Bella LL Hirschberger YH Kwon MH Stipanuk 2002 Cysteine metabolism in periportal and perivenous hepatocytes: perivenous cells have greater capacity for glutathione production and taurine synthesis but not for cysteine catabolism Amino Acids 23 4 453 458 10.1007/s00726-002-0213-z 1:CAS:528: DC%2BD38XoslOrur8%3D (Pubitemid 35435604)
4. G Schuller Levis E Park SM Gregory 2006 Is taurine a biomarker? Adv Clin Chem 41 1 21 10.1016/S0065-2423(05)41001-X 1:CAS:528:DC%2BD1cXjs1Cgu7s%3D (Pubitemid 43648628)
5. L Aerts FA Van Assche 2002 Taurine and taurine-deficiency in the perinatal period J Perinat Med 30 4 281 286 10.1515/JPM.2002.040 1:CAS:528:DC%2BD38XotFeitro%3D (Pubitemid 34976464)
6. O Beckonert J Monnerjahn U Bonk D Leibfritz 2003 Visualizing metabolic changes in breast-cancer tissue using 1H-NMR spectroscopy and self-organizing maps NMR Biomed 16 1 1 11 10.1002/nbm.797 1:CAS:528:DC%2BD3sXit1Ghtbw%3D (Pubitemid 36284830)
7. E De Micheli A Alfieri G Pinna L Bianchi MA Colivicchi A Melani F Pedata L Della Corte A Bricolo 2000 Extracellular levels of taurine in tumoral, peritumoral and normal brain tissue in patients with malignant glioma: an intraoperative microdialysis study Adv Exp Med Biol 483 621 625 10.1007/0-306-46838-7-67
8. S Srivastava R Roy S Singh P Kumar D Dalela SN Sankhwar A Goel AA Sonkar 2010 Taurine-a possible fingerprint biomarker in non-muscle invasive bladder cancer: a pilot study by 1H NMR spectroscopy Cancer Biomark 6 1 11 20
9. www.wikipedia.com. Accessed 20 May 2011
10. S Gamagedara S Gibbons Y Ma 2011 Investigation of urinary pteridine levels as potential biomarkers for noninvasive diagnosis of cancer Clin Chim Acta 412 1-2 120 128 10.1016/j.cca.2010.09.015 1:CAS:528:DC%2BC3cXhsVGkurvJ
11. H Orhan NP Vermeulen C Tump H Zappey JH Meerman 2004 Simultaneous determination of tyrosine, phenylalanine and deoxyguanosine oxidation products by liquid chromatography-tandem mass spectrometry as non-invasive biomarkers for oxidative damage J Chromatogr B Analyt Technol Biomed Life Sci 799 2 245 254 10.1016/j.jchromb.2003.10.056 1:CAS:528:DC%2BD3sXps1Ogu74%3D (Pubitemid 37510227)
12. TJ Wang MG Larson RS Vasan S Cheng EP Rhee E McCabe GD Lewis CS Fox PF Jacques C Fernandez CJ O'Donnell SA Carr VK Mootha JC Florez A Souza O Melander CB Clish RE Gerszten 2011 Metabolite profiles and the risk of developing diabetes Nat Med 17 4 448 453 10.1038/nm.2307
13. RW Pero 2009 Health consequences of catabolic synthesis of hippuric acid in humans Curr Clin Pharmacol 5 1 67 73 10.2174/157488410790410588
14. X Xu J Lan WA Korfmacher 2005 Rapid LC/MS/MS method development for drug discovery Anal Chem 77 19 389A 394A 1:CAS:528:DC%2BD2MXhtVOqtbrI
15. X Long J Zhang Y Zhang J Yao Z Cai P Yang 2009 Nano-LC-MS/MS based proteomics of hepatocellular carcinoma cells compared to Chang liver cells and tanshinone IIA induction Mol Biosyst 7 5 1728 1741 10.1039/c0mb00343c
16. MN Cohen U Christians T Henthorn Z Vu Tran V Moll J Zuk J Galinkin 2011 Pharmacokinetics of single-dose intravenous ketorolac in infants aged 2-11 months Anesth Analg 112 3 655 660 10.1213/ANE.0b013e3182075d04 1:CAS:528:DC%2BC3MXisFeiu7w%3D
17. C Wang H Shi CD Adams S Gamagedara I Stayton T Timmons Y Ma 2010 Investigation of pharmaceuticals in Missouri natural and drinking water using high performance liquid chromatography-tandem mass spectrometry Water Res 45 4 1818 1828 10.1016/j.watres.2010.11.043
18. P Chaimbault P Alberic C Elfakir M Lafosse 2004 Development of an LC-MS-MS method for the quantification of taurine derivatives in marine invertebrates Anal Biochem 332 2 215 225 10.1016/j.ab.2004.06.014 1:CAS:528:DC%2BD2cXmvFelt7k%3D (Pubitemid 39489834)
19. N Penner R Ramanathan J Zgoda-Pols S Chowdhury 2010 Quantitative determination of hippuric and benzoic acids in urine by LC-MS/MS using surrogate standards J Pharm Biomed Anal 52 4 534 543 10.1016/j.jpba.2010.01.016 1:CAS:528:DC%2BC3cXjt1KjsLc%3D
20. A Zinellu S Sotgia B Scanu R Chessa L Gaspa F Franconi L Deiana C Carru 2009 Taurine determination by capillary electrophoresis with laser-induced fluorescence detection: from clinical field to quality food applications Amino Acids 36 1 35 41 10.1007/s00726-007-0022-5 1:CAS:528:DC%2BD1MXht12guw%3D%3D
21. BL Ackermann JE Hale KL Duffin 2006 The role of mass spectrometry in biomarker discovery and measurement Curr Drug Metab 7 5 525 539 10.2174/138920006777697918 1:CAS:528:DC%2BD28XmtVajtb8%3D
22. E Ciccimaro IA Blair 2010 Stable-isotope dilution LC-MS for quantitative biomarker analysis Bioanalysis 2 2 311 341 10.4155/bio.09.185 1:CAS:528:DC%2BC3cXivFCjtL8%3D
23. F Teichert RD Verschoyle P Greaves JF Thorpe JK Mellon WP Steward PB Farmer AJ Gescher R Singh 2009 Determination of 8-oxo-2′-deoxyguanosine and creatinine in murine and human urine by liquid chromatography/tandem mass spectrometry: application to chemoprevention studies Rapid Commun Mass Spectrom 23 2 258 266 10.1002/rcm.3873 1:CAS:528:DC%2BD1MXhtVKqsLg%3D
24. YL Chung WS Wassif JD Bell M Hurley DL Scott 2003 Urinary levels of creatine and other metabolites in the assessment of polymyositis and dermatomyositis Rheumatology (Oxford) 42 2 298 303 10.1093/rheumatology/keg084 1:CAS:528:DC%2BD3sXit1yntLc%3D (Pubitemid 36305617)
25. JG Csernansky ME Bardgett YI Sheline JC Morris JW Olney 1996 CSF excitatory amino acids and severity of illness in Alzheimer's disease Neurology 46 6 1715 1720 1:STN:280:DyaK283kvV2qtw%3D%3D (Pubitemid 26185799)
26. R Dawson Jr MA Pelleymounter MJ Cullen M Gollub S Liu 1999 An age-related decline in striatal taurine is correlated with a loss of dopaminergic markers Brain Res Bull 48 3 319 324 10.1016/S0361-9230(99)00003-9 1:CAS:528: DyaK1MXivVSqsbY%3D (Pubitemid 29191173)
27. J Nanobashvili C Neumayer A Fugl A Punz R Blumer M Prager M Mittlbock H Gruber P Polterauer E Roth T Malinski I Huk 2003 Ischemia/reperfusion injury of skeletal muscle: plasma taurine as a measure of tissue damage Surgery 133 1 91 100 10.1067/msy.2003.65 (Pubitemid 36183131)